[HTML][HTML] Towards frailty biomarkers: Candidates from genes and pathways regulated in aging and age-related diseases

AL Cardoso, A Fernandes, JA Aguilar-Pimentel… - Ageing research …, 2018 - Elsevier
Objective Use of the frailty index to measure an accumulation of deficits has been proven a
valuable method for identifying elderly people at risk for increased vulnerability, disease …

[HTML][HTML] Acetaminophen-induced hepatotoxicity: a comprehensive update

E Yoon, A Babar, M Choudhary, M Kutner… - Journal of clinical and …, 2016 - ncbi.nlm.nih.gov
Hepatic injury and subsequent hepatic failure due to both intentional and non-intentional
overdose of acetaminophen (APAP) has affected patients for decades, and involves the …

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

RJ Fontana, I Liou, A Reuben, A Suzuki, MI Fiel… - Hepatology, 2023 - journals.lww.com
There are currently more than 1000 prescription medications available for use in the United
States and more than 100,000 over-the-counter herbal and dietary supplements (HDS) …

Drug-induced liver injury: recent advances in diagnosis and risk assessment

GA Kullak-Ublick, RJ Andrade, M Merz, P End… - Gut, 2017 - gut.bmj.com
Idiosyncratic drug-induced liver injury (IDILI) is a rare but potentially severe adverse drug
reaction that should be considered in patients who develop laboratory criteria for liver injury …

[PDF][PDF] Candidate biomarkers for the diagnosis and prognosis of drug‐induced liver injury: an international collaborative effort

RJ Church, GA Kullak‐Ublick, J Aubrecht… - …, 2019 - Wiley Online Library
Current blood biomarkers are suboptimal in detecting drug‐induced liver injury (DILI) and
predicting its outcome. We sought to characterize the natural variabilty and performance …

Molecular biomarkers in drug-induced liver injury: Challenges and future perspectives

S Fu, D Wu, W Jiang, J Li, J Long, C Jia… - Frontiers in …, 2020 - frontiersin.org
Drug-induced liver injury (DILI) is one among the common adverse drug reactions and the
leading causes of drug development attritions, black box warnings, and post-marketing …

Drug-induced liver injury: biomarkers, requirements, candidates, and validation

L Meunier, D Larrey - Frontiers in pharmacology, 2019 - frontiersin.org
The hepatotoxicity of drugs is the main cause of drug withdrawal from the pharmaceutical
market and interruption of the development of new molecules. Biomarkers are useful in …

[PDF][PDF] Cell death markers in patients with cirrhosis and acute decompensation

S Macdonald, F Andreola, P Bachtiger, A Amoros… - …, 2018 - Wiley Online Library
The aims of this study were to determine the role of cell death in patients with cirrhosis and
acute decompensation (AD) and acute on chronic liver failure (ACLF) using plasma‐based …

Drug-induced liver injury: highlights from a review of the 2015 literature

P Sarges, JM Steinberg, JH Lewis - Drug safety, 2016 - Springer
Numerous publications contributed to the expanding knowledge base about drug-induced
liver injury (DILI) in 2015. New findings from the US Drug Induced Liver Injury Network …

Chemokines in primary liver cancer

M Zajkowska, B Mroczko - International Journal of Molecular Sciences, 2022 - mdpi.com
The liver is responsible for extremely important functions in the human body. In the liver's
structure, we distinguish between connective tissue (stroma) and parenchyma, the latter of …